Dronedarone, sold under the brand name Multaq, is a class III antiarrhythmic medication developed by Sanofi-Aventis. [citation needed] . It was approved by the US Food and Drug …

Dronedarone is a heart rhythm medicine that helps lower your risk of needing to be hospitalized for a heart rhythm disorder called atrial fibrillation. Dronedarone is for adults who have had this …

决奈达隆是抗心律失常药物，适用于阵发性或持续性 心房颤动 (AF)或 心房扑动 (AFL)患者，减低住院风险，近期AF/AFL发作和伴心血管风险因子患者 (即年龄>70、高血压、糖尿病、既往心 …

Darekon manufactures electronics at its facilities in Haapavesi, Gdansk and Stockholm. Our main focus is the contract manufacture of medical equipment and industrial electronics. …

2023年5月10日 · Dronedarone, a noniodinated congener of amiodarone, was developed as an antiarrhythmic agent for the maintenance of sinus rhythm in patients with atrial fibrillation (AF).

Multaq适用于降低有阵发性或持续性心房颤动 (AF)病史的窦性心律患者因心房颤动住院的风险。 目前尚不清楚Multaq对18岁以下儿童是否安全有效。 Multaq的推荐剂量为成人每天两次，每 …

Dronedarone is used to treat people who currently have normal heart rhythm, but have had atrial fibrillation in the past. Dronedarone decreases the risk that people who have this condition will …

盐酸决奈达隆片禁用于近期心衰失代偿需要住院或NYHA IV级的症状性心力衰竭患者。 在永久性心房颤动患者中,盐酸决奈达隆片使死亡、卒中和因心力衰竭住院的风险加倍。 盐酸决奈达隆片 …

2011年12月15日 · Dronedarone restores sinus rhythm and reduces hospitalization or death in intermittent atrial fibrillation. It also lowers heart rate and blood pressure and has...

Monitor EKG every 3 months; if in atrial fib, then either stop dronedarone or cardiovert. Use appropriate antithrombotic therapy prior to and concurrently with dronedarone. If suspected …